Prognostic impact of atrial fibrillation in patients undergoing transcatheter aortic valve implantation
AF was associated with increased mortality at 1 year and higher rates of stroke and major bleeding at 30 days and 1 year after TAVI.
Authors
- Gregor Leibundgut (ORCID: https://orcid.org/0000-0002-0122-5397)
- Thorald Stolte (ORCID: https://orcid.org/0000-0001-9840-7818)
- Felix Mahfoud (ORCID: https://orcid.org/0000-0002-4425-549X)
- Jakob Johannes Reichl (ORCID: https://orcid.org/0009-0007-2497-7587)
- Michael Kühne (ORCID: https://orcid.org/0000-0002-2937-3711)
- Thomas Nestelberger (ORCID: https://orcid.org/0000-0003-2173-5738)
- Max Wagener (ORCID: https://orcid.org/0000-0002-7970-8989)
- Patrick Badertscher (ORCID: https://orcid.org/0000-0001-9751-0557)
- Jasper Boeddinghaus (ORCID: https://orcid.org/0000-0003-4404-4956)
- Christian Sticherling (ORCID: https://orcid.org/0000-0001-8428-7050)
- Christoph Kaiser (ORCID: https://orcid.org/0000-0002-9463-0892)
Institutions
- University of Basel (CH)
- University Hospital of Basel (CH)
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1016/j.hroo.2024.12.016
- Citations
- 3
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- National Science Foundation
- Amgen
- Edwards Lifesciences
- Universität Basel
- ReCor Medical
- Universitätsspital Basel
- Deutsche Forschungsgemeinschaft
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität des Saarlandes
- Gottfried und Julia Bangerter-Rhyner-Stiftung
- Deutsche Herzstiftung
- Schweizerische Akademie der Medizinischen Wissenschaften
- Medizinische Abteilung der Margarete und Walter Lichtenstein-Stiftung
- Servier